BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Prasoppokakorn T, Chan WK, Wong VWS, Pitisuttithum P, Mahadeva S, Nik Mustapha NR, Wong GLH, Leung HHW, Sripongpun P, Treeprasertsuk S. Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease . World J Gastroenterol 2022; 28(15): 1563-1573 [PMID: 35582126 DOI: 10.3748/wjg.v28.i15.1563]
URL: https://www.wjgnet.com/1007-9327/full/v28/i15/1563.htm
Number Citing Articles
1
Xiuru Gong, Yaxin Guo, Tingting Zhu, Dongwei Xing, Qi Shi, Minguang Zhang. Noninvasive assessment of significant liver fibrosis in rabbits by spectral CT parameters and texture analysisJapanese Journal of Radiology 2023; 41(9): 983 doi: 10.1007/s11604-023-01423-0
2
Mosca Antonella, Andrea Pietrobattista, Giuseppe Maggiore. Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?Pediatric Reports 2024; 16(2): 288 doi: 10.3390/pediatric16020025
3
Hao-ming He, Shu-wen Zheng, Yi-nong Chen, Long-yang Zhu, Zhe Wang, Si-qi Jiao, Fu-rong Yang, Yi-hong Sun. A Comparison of the Prognostic Value of Liver Fibrosis Scores in Acute Myocardial Infarction Patients With and Without Type 2 DiabetesAngiology 2024; 75(3): 219 doi: 10.1177/00033197231197230
4
Hanzhu Chen, Wenya Ren, Xingdi Yang, Piao Hu, Shouhao Wang, Chengan Xu, Fei Lv, Yue Zhao, Qiaoqiao Yin, Wei Zheng, Jing Xu, Hongying Pan. Development and validation of a noninvasive prediction model for significant hepatic liver fibrosis in Chinese patients with autoimmune hepatitisAnnals of Hepatology 2024; 29(3): 101287 doi: 10.1016/j.aohep.2024.101287
5
C. Vikneshwaran Chandra Kumar, Ruben Skantha, Wah-Kheong Chan. Non-invasive assessment of metabolic dysfunction–associated fatty liver diseaseTherapeutic Advances in Endocrinology and Metabolism 2022; 13: 204201882211396 doi: 10.1177/20420188221139614